Abstract Submission

SUBMIT YOUR ORIGINAL RESEARCH TO ANR2018 IN SAN FRANCISCO!

 

The scientific organizers welcome the submission of original Neuroblastoma research for presentation at ANR2018 in San Francisco.  The biennial Advances in Neuroblastoma Research Congress is the leading international forum for sharing the most recent advances in basic, translational and clinical Neuroblastoma research.

ANR welcomes the submission of abstracts on the topics listed below. To facilitate the review process, three abstract categories have been developed for ANR2018, and the submission site will open in the Fall of 2017.

Basic Biology

MYCN/MYC
ALK
RAS
Telomerase/telomeres
Other critical pathways
Genetics and epigenetics
Genome-wide analysis
Genomic instabiility/DNA repair
Non-coding RNA
Chromatin modification
Transcription
Translation control/mrna
Developmental biology
Tumor initiaton and cancer stem cells
Metastasis
Apoptosis/cell death
Immunology/TME

Translational

Animal models
Preclinical trials
Novel targeted therapy (preclinical)
Preclinical screening/technology
Preclinical biomarker/technology
Therapy response and resistance

Clinical

Early phase clinical trials
Novel targeted therapy in development (clinical)
Immunotherapy
Clinical trial biomarker development and design
Imaging and diagnostics
Radiation therapy
Nuclear medicine
Nursing related topics
Trials in countries with limited resources
Surgery
Survivorship and late effects

 

Abstract submission site opens in the Fall of 2017!